IL-23 inhibitor guselkumab shows promise for PsA
نویسندگان
چکیده
منابع مشابه
Gene therapy for Parkinson's disease shows promise.
CLINICAL TRIALS NEUROLOGICAL DISEASES ARE AMONG THE MOST INTERESTING APPLICATIONS FOR gene therapy. A er decades of preclinical development, viral vector–based gene transfer has now reached the clinic, and early-stage clinical trials are currently in progress in three areas: congenital blindness and retinal degeneration; the childhood metabolic disorder Bat-ten disease; and the progressive neur...
متن کاملSelective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor.
The interleukin-12 (IL-12) cytokine induces the differentiation of naive T cells to the T helper cell type 1 (Th1) phenotype and is integral to the pathogenesis of Th1-mediated immunologic disorders. A more recently discovered IL-12 family member, IL-23, shares the p40 protein subunit with IL-12 and plays a critical role in the generation of effector memory T cells and IL-17-producing T cells. ...
متن کاملTherapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis
INTRODUCTION The purpose of this study was to determine if oral administration of the interleukin (IL) 12/IL-23 inhibitor, STA-5326, is effective in experimental autoimmune uveoretinitis (EAU). METHODS C57BL/6J mice were immunised with human interphotoreceptor retinoid binding protein peptide (IRBP 1-20). STA-5326 at a dose of either 5 mg/kg or 20 mg/kg, or vehicle alone, was orally administe...
متن کاملPreliminary breast cancer vaccine study shows promise.
A vaccine designed to treat breast cancer has performed surprisingly well in an initial clinical study. In a phase II trial of 186 patients, the vaccine targeting the HER2/neu E75 peptide reduced the risk of recurrence by 50% in 101 breast cancer patients who were clinically disease free after treatment compared with those who were not treated with the vaccine. Immunized patients also had about...
متن کاملPolypill Shows Promise for Reducing Cardiovascular Disease Risk Factors
Setting and participants. Between March 2007 and August 2008, 2053 individuals aged 45 to 80 years were recruited from 50 centers across India if they had no cardiovascular disease (CVD) but at least 1 of the following CVD risk factors: smoker within past 5 years, type 2 diabetes, blood pressure >140 mm Hg systolic or 90 mm Hg diastolic, abnormal lipid levels (low-density lipoprotein [LDL] chol...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Rheumatology
سال: 2020
ISSN: 1759-4790,1759-4804
DOI: 10.1038/s41584-020-0420-6